Literature DB >> 16002076

Leukocyte CD40L deficiency affects the CD25(+) CD4 T cell population but does not affect atherosclerosis.

M L F Smook1, P Heeringa, J G M C Damoiseaux, M J A P Daemen, M P J de Winther, M J J Gijbels, L Beckers, E Lutgens, J W Cohen Tervaert.   

Abstract

Inhibition of CD40-CD40L interactions results in a reduction of innate regulatory T cells (Tregs) in CD40(-/-) mice and induces a stable plaque phenotype in atherosclerosis-prone mouse strains. Here we investigated the effects of leukocyte CD40L on the Treg population and on atherosclerosis. LDLR(-/-) mice were reconstituted with wild-type or CD40L(-/-) bone marrow (BM). These BM chimeras were analysed by flow cytometry for the presence of innate Tregs (CD45RB(low) CD25(+) CD4) in lymphoid organs and peripheral blood. As in CD40(-/-) mice, the CD45RB(high):CD45RB(low) CD4 T cell ratio significantly increased and the CD25(+) CD4(+) subpopulation significantly decreased in LDLR(-/-) mice receiving CD40L(-/-) BM compared to LDLR(-/-) mice receiving wild-type BM. However, atherosclerotic plaque progression and plaque phenotype did not change in LDLR(-/-) mice reconstituted with CD40L(-/-) BM. In conclusion, the present study shows that CD40-CD40L interactions on leukocytes are essential for the size of the CD45RB(low) CD25(+) CD4 Treg subpopulation. Nevertheless, CD40L deficiency on hemopoietic cells did not affect atherosclerosis, implying that CD40L expressing leukocytes alone are not responsible for the stable plaque phenotype observed after total CD40L blockade.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002076     DOI: 10.1016/j.atherosclerosis.2005.03.051

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

Review 1.  ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis.

Authors:  Klaus Ley; Norbert Gerdes; Holger Winkels
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-30       Impact factor: 8.311

Review 2.  Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.

Authors:  Leslie S Kean; Laurence A Turka; Bruce R Blazar
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

3.  Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice.

Authors:  Dennis Wolf; Jan-David Hohmann; Ansgar Wiedemann; Kamila Bledzka; Hermann Blankenbach; Timoteo Marchini; Katharina Gutte; Katharina Zeschky; Nicole Bassler; Natalie Hoppe; Alexandra Ortiz Rodriguez; Nadine Herr; Ingo Hilgendorf; Peter Stachon; Florian Willecke; Daniel Duerschmied; Constantin von zur Muhlen; Dmitry A Soloviev; Li Zhang; Christoph Bode; Edward F Plow; Peter Libby; Karlheinz Peter; Andreas Zirlik
Journal:  Circ Res       Date:  2011-10-13       Impact factor: 17.367

Review 4.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

Review 5.  The complex role of T-cell-based immunity in atherosclerosis.

Authors:  Pål Aukrust; Kari Otterdal; Arne Yndestad; Wiggo J Sandberg; Camilla Smith; Thor Ueland; Erik Øie; Jan K Damås; Lars Gullestad; Bente Halvorsen
Journal:  Curr Atheroscler Rep       Date:  2008-06       Impact factor: 5.113

Review 6.  T-cell costimulation and coinhibition in atherosclerosis.

Authors:  Israel Gotsman; Arlene H Sharpe; Andrew H Lichtman
Journal:  Circ Res       Date:  2008-11-21       Impact factor: 17.367

Review 7.  The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis.

Authors:  Ricardo F Antunes; Juan Carlos Kaski; Ingrid E Dumitriu
Journal:  J Biomed Biotechnol       Date:  2011-12-22

8.  Bone marrow-specific knock-in of a non-activatable Ikkα kinase mutant influences haematopoiesis but not atherosclerosis in Apoe-deficient mice.

Authors:  Pathricia V Tilstam; Marion J Gijbels; Mohamed Habbeddine; Céline Cudejko; Yaw Asare; Wendy Theelen; Baixue Zhou; Yvonne Döring; Maik Drechsler; Lukas Pawig; Sakine Simsekyilmaz; Rory R Koenen; Menno P J de Winther; Toby Lawrence; Jürgen Bernhagen; Alma Zernecke; Christian Weber; Heidi Noels
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

Review 9.  TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases.

Authors:  Luis M Blanco-Colio
Journal:  Front Immunol       Date:  2014-01-20       Impact factor: 7.561

10.  Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease.

Authors:  Michael Lacy; Christina Bürger; Annelie Shami; Maiwand Ahmadsei; Holger Winkels; Katrin Nitz; Claudia M van Tiel; Tom T P Seijkens; Pascal J H Kusters; Ela Karshovka; Koen H M Prange; Yuting Wu; Sanne L N Brouns; Sigrid Unterlugauer; Marijke J E Kuijpers; Myrthe E Reiche; Sabine Steffens; Andreas Edsfeldt; Remco T A Megens; Johan W M Heemskerk; Isabel Goncalves; Christian Weber; Norbert Gerdes; Dorothee Atzler; Esther Lutgens
Journal:  Nat Commun       Date:  2021-06-18       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.